Sign in

Sphera Funds Management LTD.

CIK:0001496201
Hedge Fund
$2B AUM
110 holdings
Tel Aviv, Israel
Founded:2004
75 employees
Latest filing:Jun 30, 2025

Sphera Funds Management Ltd. is an Israel-based hedge fund firm founded in 2004 and headquartered in Tel Aviv. The firm manages a suite of hedge funds, with a specialty in healthcare and related sectors. Serving institutional and sophisticated international investors, Sphera employs a team of around 51-100 professionals and is recognized as one of the more prominent alternative investment managers in the Israeli market.

Investment Strategy

Sphera Funds Management Ltd. implements sector-focused, research-driven long/short equity strategies, primarily in healthcare and global markets. The firm emphasizes fundamental analysis and rigorous risk management. Their funds often leverage deep sector expertise to generate alpha through identifying undervalued growth opportunities and managing downside risk via both long and short positions.

Top Buys
T
TSEMTOWER SEMICONDUCTOR LTD
+$9.3M
B
BIIBBIOGEN INC
+$7.3M
F
FBRXFORTE BIOSCIENCES INC
+$6.4M
C
CDTXCIDARA THERAPEUTICS INC
+$6.4M
F
FOLDAMICUS THERAPEUTICS INC
+$5.7M
Top Sells
B
BBIOBRIDGEBIO PHARMA INC
-$8.9M
S
SRPTSAREPTA THERAPEUTICS INC
-$7.4M
S
SNYSANOFI
-$6.3M
R
RAREULTRAGENYX PHARMACEUTICAL IN
-$6.0M
S
SNDXSYNDAX PHARMACEUTICALS INC
-$5.7M

Top Holdings

T
TEVATEVA PHARMACEUTICAL INDS LTD
+6.4%$27.2M
N
NVMINOVA LTD
+4.9%$20.9M
S
SNDXSYNDAX PHARMACEUTICALS INC
+3.5%$14.7M
T
TSEMTOWER SEMICONDUCTOR LTD
+2.7%$11.5M
C
CYTKCYTOKINETICS INC
+2.5%$10.8M

Equity Positions (97)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
T
TEVA
TEVA PHARMACEUTICAL INDS LTD6.38%$27.2M1,620,990$15.12$16.76+$3.0M
N
NVMI
NOVA LTD4.90%$20.9M75,836$200.34$275.20+$4.2M
S
SNDX
SYNDAX PHARMACEUTICALS INC3.45%$14.7M1,571,564$16.69$9.37-$5.7M
T
TSEM
TOWER SEMICONDUCTOR LTD2.69%$11.5M264,722$41.08$43.35+$9.3M
C
CYTK
CYTOKINETICS INC2.53%$10.8M326,718$37.36$33.04+$5.0M

Options Positions (9)

TickerSecurityActionTypeNotional ValueContractsUnderlying PricePremium PaidChange (Contracts)Change (Value)
X
XBI
SPDR SERIES TRUSTNew
Put
$16.6M2,000$82.93$82.93+2,000+$16.6M
R
RARE
ULTRAGENYX PHARMACEUTICAL INBought
Call
$6.6M1,806$36.36$36.32+1,306+$4.8M
M
MLTX
MOONLAKE IMMUNOTHERAPEUTICSNew
Call
$5.9M1,250$47.20$47.20+1,250+$5.9M
P
PRAX
PRAXIS PRECISION MEDICINES I
Call
$4.2M1,000$42.05$56.010+$418.0K
T
TLT
ISHARES TRSold
Call
$4.1M470$88.25$91.03-2,081-$19.1M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+59.1%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+9.7%
SEMICONDUCTORS & RELATED DEVICES
+6.7%
OPTICAL INSTRUMENTS & LENSES
+5.5%
SERVICES-PREPACKAGED SOFTWARE
+2.4%